Finding the most promising indications for novel treatments in oncology.
Saved in:
| Title: | Finding the most promising indications for novel treatments in oncology. |
|---|---|
| Authors: | Eckhoff M; McKinsey & Company, London, UK., Klingelschmitt S; Boehringer Ingelheim, Ingelheim, Germany., Van Ruijssevelt L; McKinsey & Company, Brussels, Belgium., Grossmann S; McKinsey & Company, Berlin, Germany., Zichner T; Boehringer Ingelheim, Vienna, Austria., Stümpges P; McKinsey & Company, Frankfurt, Germany. Paul_Stuempges@mckinsey.com., Roschewitz D; McKinsey & Company, London, UK., Mlecnik B; Boehringer Ingelheim, Vienna, Austria., Merger M; Boehringer Ingelheim, Ingelheim, Germany., Graen P; Boehringer Ingelheim, Ingelheim, Germany., Kumar J; Boehringer Ingelheim, Ingelheim, Germany., Devereson A; McKinsey & Company, London, UK., Wurzer S; McKinsey & Company, Munich, Germany., Bleys J; McKinsey & Company, Charlotte, NC, USA., Albrecht B; McKinsey & Company, Paris, France., Hach D; Boehringer Ingelheim, Ingelheim, Germany., Haslinger C; Boehringer Ingelheim, Vienna, Austria. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2026 Mar 25; Vol. 10 (1). Date of Electronic Publication: 2026 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-026-01352-x |
